Mylan Aims To Nix FDA Approval Of Teva's Generic Provigil
Mylan Inc. sued the U.S. Food and Drug Administration on Thursday seeking to derail the marketing exclusivity period the agency awarded Teva Pharmaceuticals USA Inc. for a generic version of Cephalon...To view the full article, register now.
Already a subscriber? Click here to view full article